Thursday, April 30, 2026
FB X LI YT
Breaking
“Stay out of Oyo affairs” — Think Yoruba First fires warning at Nonentity Igbo group over comments on Olubadan stool, political matters “Genocidal and diabolical” — Think Yoruba First blasts Farooq Kperogi over claims that Ilorin, Shao, Jebba are not Yoruba towns 🇳🇬📚 Ridwan Ajayi emerges new NANS JCC Lagos chairman after 5-5 tiebreaker vote — 10 tertiary institutions participated 🇳🇬📜 130 CIVIL SOCIETY GROUPS PETITION KWARA GOVERNOR OVER DELAY OF BAALE’S UPGRADE LETTER — ACCUSE COMMISSIONER OF BLOCKING ELEVATION ON OBAS’ ORDERS! 🇳🇬🎀 RIHANNA WEARS YORUBA GELE — A Global Icon Embraces Our Heritage, Proving Gele Will Never Be Reduced to a Slur! 🇳🇬🔥 FAVORITISM UNMASKED: Seyi Tinubu Empowers Imo Youth With Freezers, Gives Yorubaland Rice and Foodstuffs That Will Finish in a Week — Is It Because His Wife Is Igbo? The first revelation landed like a thunderbolt. Ella, the face of the campaign against Omotoso, had privately apologized to him. That apology never made it online. According to the Commissioner, it was omitted because it did not serve what he described as a calculated clout-chasing agenda. The public was fed a version of events designed to provoke outrage, not inform discourse. 🇳🇬💔 2000 KADUNA RELIGIOUS CRISIS: When Sharia Introduction Sparked Bloodshed — Over 500 Feared Dead, Churches, Mosques, Businesses Razed!
NEWS

Africa Begins Rollout of Groundbreaking HIV-Prevention Injection

December 1, 2025 • 2 min read

December 1, 2025
By Ayinde Adeleke

African health authorities have begun administering Lenacapavir, a groundbreaking HIV-prevention injection that has shown remarkable success in reducing the risk of HIV transmission by more than 99.9 percent. The long-acting drug, taken just twice a year, is being described by medical experts as one of the most significant advancements in HIV prevention to date, with its effectiveness making it “functionally comparable to a powerful vaccine.”

The rollout officially commenced today in South Africa, Eswatini, and Zambia, three countries with some of the highest HIV prevalence rates globally. Public health officials say the introduction of Lenacapavir represents a major step forward in the continent’s ongoing efforts to curb new infections and expand access to reliable preventive care.

Developed as a biannual injection, Lenacapavir works by blocking the virus from replicating in the body, offering long-term protection for individuals at high risk of exposure. Its extended dosing schedule is expected to improve adherence, particularly among vulnerable groups who may struggle with daily or monthly medication routines.

Regional health ministries have expressed optimism that the new injection will significantly reduce transmission rates, ease the burden on healthcare systems, and accelerate progress towards achieving global HIV-reduction targets. International health partners and donor agencies have also pledged support to ensure equitable access as more African countries prepare to join the rollout.

The introduction of Lenacapavir has been widely praised by public health advocates as a transformative milestone for HIV prevention in Africa, with experts calling it a critical tool in the continent’s fight to end new infections in the coming decades.